📢 We are pleased to share the latest issue of DRAP's Newsletter! 🌟
Stay updated with the latest developments, initiatives, and insights into healthcare and medicine regulation in Pakistan.
📰 Click here to read: https://t.co/Ae7ZtWsOF5
#Pharmaceutical#ClinicalTrials#drug
Not all medicines are suitable for everyone 👧🏾👨🏻🦳🤰🏻
As a healthcare professional, you can help prevent side effects by reviewing therapies before prescribing or administering them.
Together we can help #PreventSideEffects and improve #PatientSafety. #MedSafetyWeek
📣 #MedSafetyWeek kicks off today!
Throughout the week we are sharing ways to help #PreventSideEffects and encouraging people to report suspected side effects from medicines.
Help us monitor the safety of all medicines, #ReportSideEffects at 👉 https://t.co/fzSLRUzq4J
@DRA_Pakistan & @WHOPakistan are collaborating to enhance the regulatory framework of Pakistan. The WHO Representative in Pakistan, H.E. Dr. Depang Lu, visited DRAP HQ and met with Mr. Asim Rauf, CEO DRAP and his team.
@DRA_Pakistan signed a letter of understanding with the Fleming Fund country Grant -DAI Pakistan for the development and strengthening of the national antimicrobial consumption surveillance system.
@DRA_Pakistan & @WHOPakistan organized a two-day Expert consultative meeting on June 25-26, 2024, in Islamabad. This significant event aimed to enhance the national capacity for conducting randomized controlled trials and large-scale studies. Details 👉 https://t.co/CwdzqaVLsR
🚀 *Exciting News* ! DRAP, in collaboration with @UMCGlobalSafety has launched VigiFlow eForms, including Med Vigilance E-Reporting & VigiMobile for ADR reporting, now in *Urdu* ! 🇵🇰. Scan the QR code to access & download the 📱app. #Pharmacovigilance
https://t.co/fzSLRUzXUh
A delegation of 🇵🇰 pharmaceutical manufacturers, set to accompany the H.E. Prime Minister on his visit to 🇨🇳, met with the CEO DRAP today. A major outcome of this visit will be the transfer of technology & new ventures in the pharma & medical device fields as per vision of GOP.
This system tracks application processing, allowing applicants to monitor their regulatory submissions and provide additional details as needed, significantly enhancing transparency and efficiency 2/2.
An orientation session for senior DRAP officers on the case management system of the E-App module was arranged today. DRAP has launched a centralized case management system to improve operational efficiency and streamline business processes for the therapeutic goods industry. 1/2
Mr. Maksim Kerdzialevich, Second Secretary of the Embassy of the Republic of Belarus, met with @DRA_Pakistan CEO Mr.Asim Rauf to discuss enhancing cooperation and collaboration between DRAP and the Republican Unitary Enterprise,Center for Examinations and Tests in Health Service.
Mr Asim Rauf, CEO @DRA_Pakistan called upon an important meeting on strengthening coordination in all federating units on menace of substandard and falsified therapeutic goods. The meeting was attended by the provincial Chief Drug Controllers. Details 👇
https://t.co/QzNqRUsVCo
🔬 Are you a qualified expert in the pharmaceutical field? 💊
📢 @DRA_Pakistan is calling for applications for nomination of expert members of the Central Licensing Board! 📢
🌟 Join DRAP in shaping the future of healthcare in Pakistan! 🌟
#Healthcare#Pharmaceuticals#JoinUs
*DRAP's Safety Alert🚨"
DRAP has detected 4 drug products including one human and three veterinary injections contaminated with ethylene glycol (EG) at unacceptable levels. These injections were analyzed by the Central Drug Laboratory Karachi. Details👇
https://t.co/qdrOiVBHHh
Today, we had a fruitful meeting with reps from the Gates MRI to discuss the conduct of clinical trials in Pakistan. Appreciate their commitment & sharing of knowledge. At DRAP, we prioritize safety, ethics, and quality in clinical research.
#ClinicalTrials#Healthcare#DRAP
It was a delight to speak with young pharmacists during an educational session organized by the Punjab Pharmacy Council. Participants in the session were able to network, connect, and learn from experienced pharmacists.